Xingxing He

5.9k total citations · 2 hit papers
80 papers, 3.9k citations indexed

About

Xingxing He is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Xingxing He has authored 80 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 27 papers in Cancer Research and 25 papers in Epidemiology. Recurrent topics in Xingxing He's work include MicroRNA in disease regulation (18 papers), Cancer Mechanisms and Therapy (13 papers) and RNA modifications and cancer (13 papers). Xingxing He is often cited by papers focused on MicroRNA in disease regulation (18 papers), Cancer Mechanisms and Therapy (13 papers) and RNA modifications and cancer (13 papers). Xingxing He collaborates with scholars based in China, United States and Sweden. Xingxing He's co-authors include Ying Chang, Ju‐Sheng Lin, Chuanrui Xu, Shuzhen Sun, Dong Xu, Jusheng Lin, Peiyuan Li, Xiangyuan Luo, Jiazhi Liao and Kongming Wu and has published in prestigious journals such as Gastroenterology, PLoS ONE and Diabetes.

In The Last Decade

Xingxing He

79 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hepatogastroenterology

2012 835 citations Xingxing He, Ying Chang et al. profile →
Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets

2021 140 citations Xiangyuan Luo, Kongming Wu et al. Journal of Experimental & Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xingxing He China	32	2.1k	1.4k	729	600	564	80	3.9k
Ying Han China	36	2.0k 1.0×	1.0k 0.7×	767 1.1×	951 1.6×	753 1.3×	235	4.3k
Ilona Kovalszky Hungary	40	2.1k 1.0×	1.0k 0.7×	703 1.0×	932 1.6×	617 1.1×	182	4.8k
Xiaojie Lu China	34	2.1k 1.0×	1.1k 0.8×	518 0.7×	758 1.3×	299 0.5×	113	3.8k
Jingjing Yang China	35	2.5k 1.2×	1.3k 0.9×	984 1.3×	483 0.8×	304 0.5×	91	3.9k
Shengli Yang China	33	2.0k 1.0×	845 0.6×	407 0.6×	1.0k 1.7×	291 0.5×	167	4.0k
Weiling He China	31	1.9k 0.9×	1.2k 0.8×	388 0.5×	877 1.5×	292 0.5×	94	3.7k
Wei He China	27	1.3k 0.6×	797 0.6×	390 0.5×	558 0.9×	338 0.6×	134	2.9k
Le‐Xing Yu China	22	2.2k 1.1×	1.2k 0.9×	825 1.1×	1.1k 1.8×	363 0.6×	27	3.9k
Yuan Yang China	37	4.1k 2.0×	3.4k 2.5×	667 0.9×	787 1.3×	566 1.0×	134	6.0k

Countries citing papers authored by Xingxing He

Since Specialization

Citations

This map shows the geographic impact of Xingxing He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingxing He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingxing He more than expected).

Fields of papers citing papers by Xingxing He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingxing He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingxing He. The network helps show where Xingxing He may publish in the future.

Co-authorship network of co-authors of Xingxing He

This figure shows the co-authorship network connecting the top 25 collaborators of Xingxing He. A scholar is included among the top collaborators of Xingxing He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingxing He. Xingxing He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Yupeng, Huan Chen, Mengxian Tu, et al.. (2025). A dynamic molecular landscape in colorectal cancer progression at single-cell resolution. Journal of Translational Medicine. 23(1). 723–723.

Lu, Jingyi, Hang Su, Xingxing He, et al.. (2024). One-Hour Postload Glucose Is a More Sensitive Marker of Impaired β-Cell Function Than Two-Hour Postload Glucose. Diabetes. 74(1). 36–42. 3 indexed citations

Yuan, Yuan, et al.. (2023). DLAT as a Cuproptosis Promoter and a Molecular Target of Elesclomol in Hepatocellular Carcinoma. Current Medical Science. 43(3). 526–538. 27 indexed citations

Wang, Chun, Zhihang Chen, Yang Ding, et al.. (2023). RBM45 reprograms lipid metabolism promoting hepatocellular carcinoma via Rictor and ACSL1/ACSL4. Oncogene. 43(5). 328–340. 17 indexed citations

Luo, Xiangyuan, Kongming Wu, & Xingxing He. (2021). Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets. Journal of Experimental & Clinical Cancer Research. 40(1). 172–172. 140 indexed citations breakdown →

Han, Bing, Yang Yang, Jiang Chen, et al.. (2019). PRSS23 knockdown inhibits gastric tumorigenesis through EIF2 signaling. Pharmacological Research. 142. 50–57. 19 indexed citations

Chen, Yuhua, Lingling Meng, Haitao Shang, et al.. (2018). β2 spectrin-mediated differentiation repressed the properties of liver cancer stem cells through β-catenin. Cell Death and Disease. 9(4). 424–424. 15 indexed citations

Zhao, Pengxuan, Yao Cheng, Jia You, et al.. (2017). MiR-375 delivered by lipid-coated doxorubicin-calcium carbonate nanoparticles overcomes chemoresistance in hepatocellular carcinoma. Nanomedicine Nanotechnology Biology and Medicine. 13(8). 2507–2516. 52 indexed citations

Zuo, Peng, et al.. (2015). Non-HDL-cholesterol to HDL-cholesterol ratio as an independent risk factor for the development of chronic kidney disease. Nutrition Metabolism and Cardiovascular Diseases. 25(6). 582–587. 54 indexed citations

10.

He, Xingxing, et al.. (2015). Matrine-induced autophagy regulated by p53 through AMP-activated protein kinase in human hepatoma cells. International Journal of Oncology. 47(2). 517–526. 41 indexed citations

11.

He, Xingxing, Yu‐Nan Zhang, Junwei Yan, et al.. (2015). CP-31398 inhibits the growth of p53-mutated liver cancer cells in vitro and in vivo. Tumor Biology. 37(1). 807–815. 22 indexed citations

12.

He, Xingxing, Shuzhen Kuang, Jiazhi Liao, et al.. (2014). The regulation of microRNA expression by DNA methylation in hepatocellular carcinoma. Molecular BioSystems. 11(2). 532–539. 60 indexed citations

13.

Yang, Tan, Bin Li, Shibo Qi, et al.. (2014). Co-delivery of Doxorubicin and Bmi1 siRNA by Folate Receptor Targeted Liposomes Exhibits Enhanced Anti-Tumor Effects in vitro and in vivo. Theranostics. 4(11). 1096–1111. 83 indexed citations

14.

He, Xingxing, Yang Hong, Jin Li, et al.. (2012). Association of a TANK Gene Polymorphism with Outcomes of Hepatitis B Virus Infection in a Chinese Han Population. Viral Immunology. 25(1). 73–78. 11 indexed citations

15.

Duan, Quanlu, Xingxu Wang, Wei Gong, et al.. (2012). ER Stress Negatively Modulates the Expression of the miR-199a/214 Cluster to Regulates Tumor Survival and Progression in Human Hepatocellular Cancer. PLoS ONE. 7(2). e31518–e31518. 129 indexed citations

16.

Chang, Ying, Wei Yan, Xingxing He, et al.. (2012). miR-375 Inhibits Autophagy and Reduces Viability of Hepatocellular Carcinoma Cells Under Hypoxic Conditions. Gastroenterology. 143(1). 177–187.e8. 252 indexed citations

17.

Hong, Yang, Xingxing He, Man Chen, et al.. (2012). Association of Ephrin receptor A3 gene polymorphism with susceptibility to chronic severe hepatitis B. Hepatology Research. 42(8). 790–797. 4 indexed citations

18.

Wang, Zhijun, Fang Liu, Wei Tu, et al.. (2011). Embryonic liver fodrin involved in hepatic stellate cell activation and formation of regenerative nodule in liver cirrhosis. Journal of Cellular and Molecular Medicine. 16(1). 118–128. 19 indexed citations

19.

He, Xingxing, Ying Chang, Fanying Meng, et al.. (2010). Persistent Effect of IFNAR-1 Genetic Polymorphism on the Long-Term Pathogenesis of Chronic HBV Infection. Viral Immunology. 23(3). 251–257. 28 indexed citations

20.

He, Xingxing, Ju‐Sheng Lin, Ying Chang, et al.. (2008). Effects of two novel nucleoside analogues on different hepatitis B virus promoters. World Journal of Gastroenterology. 14(12). 1836–1836. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact